MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2397-768X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression ; volume:6 ; number:1 ; day:23 ; month:11 ; year:2022 ; pages:1-15 ; date:12.2022
npj precision oncology ; 6, Heft 1 (23.11.2022), 1-15, 12.2022
- Creator
-
Farnsworth, Dylan A.
Inoue, Yusuke
Johnson, Fraser D.
Rappard-Yuswack, Georgia de
Lu, Daniel
Shi, Rocky
Ma, Lok In Josephine
Mattar, Marissa S.
Somwar, Romel
Ladanyi, Marc
Unni, Arun M.
Lockwood, William W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-022-00328-x
- URN
-
urn:nbn:de:101:1-2023020509055172475687
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Farnsworth, Dylan A.
- Inoue, Yusuke
- Johnson, Fraser D.
- Rappard-Yuswack, Georgia de
- Lu, Daniel
- Shi, Rocky
- Ma, Lok In Josephine
- Mattar, Marissa S.
- Somwar, Romel
- Ladanyi, Marc
- Unni, Arun M.
- Lockwood, William W.
- SpringerLink (Online service)
Other Objects (12)
TIPE2 inhibits melanoma progression through MEK/ERK signaling
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Transkriptionelle Netzwerke der RAS-abhängigen, MEK-ERK-vermittelten Transformation
Relevanz des MEK/ERK-Signalweges in der hepatischen Karzinogenese
Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii
Transiente Hypoxie schützt Endothelzellen vor Apoptose über MEK-ERK-vermittelte Bad-Phosphorylierung
Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway
Transiente Hypoxie schützt Endothelzellen vor Apoptose über MEK-ERK-vermittelte Bad-Phosphorylierung
Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategies
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
TIPE2 inhibits melanoma progression through MEK/ERK signaling
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Transkriptionelle Netzwerke der RAS-abhängigen, MEK-ERK-vermittelten Transformation
Relevanz des MEK/ERK-Signalweges in der hepatischen Karzinogenese
Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii
Transiente Hypoxie schützt Endothelzellen vor Apoptose über MEK-ERK-vermittelte Bad-Phosphorylierung
Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway
Transiente Hypoxie schützt Endothelzellen vor Apoptose über MEK-ERK-vermittelte Bad-Phosphorylierung
Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategies
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
TIPE2 inhibits melanoma progression through MEK/ERK signaling
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Transkriptionelle Netzwerke der RAS-abhängigen, MEK-ERK-vermittelten Transformation
Relevanz des MEK/ERK-Signalweges in der hepatischen Karzinogenese
Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii
Transiente Hypoxie schützt Endothelzellen vor Apoptose über MEK-ERK-vermittelte Bad-Phosphorylierung
Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway
Transiente Hypoxie schützt Endothelzellen vor Apoptose über MEK-ERK-vermittelte Bad-Phosphorylierung
Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategies
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor